×
ADVERTISEMENT

APRIL 27, 2025

Forging Better Immune Globulin Outcomes

By Marcus A. Banks

Two new studies presented at the IgNS 2024 National Conference, in Washington, D.C., offer insight into treatment options for immune globulin (IG) therapy.


Protection Against SARS-CoV-2

In the second study (poster 106), researchers determined that plasma-derived IG infusions for treating PI provide some antibody protection against SARS-CoV-2.

“During the pandemic, we got a lot of questions about the antibody levels in our products,” said Kim Clark, PharmD, MBA, IgCP,